SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AlienTech who wrote (11649)7/16/1998 9:46:00 PM
From: VLAD  Read Replies (2) of 23519
 
Hey alien,

I think the Viagra lawsuit expains the after hour trades at 8 7/16.

Some poor desperate shorts were trying to cover before tomorrow when the media starts to play with it. Would be nice to see the beginings of a nice short squeeze. I think this news may bring on a lot of institutional buying of Vivus now that the safety issues will become a forced play against Pfizer. This will help provide more juice for the money managers to wake up and see that vivus at 7.5 is dirt cheap. If the money managers believe that domestic MUSE sales will kick in especially due to safety issues they may very well buy up Vivus to at least 10 or 11 in a few days and then some deep pockets might want to start to put the squeeze on that 100+million worth of short interest which can turn into 200+million pretty fast if they don't start covering until above 13 or 14.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext